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Abstract 
Where information about the appropriateness of a surgical procedure is lacking, expert 
panels have been used to establish guidelines for medical practitioners. Such a panel was 
convened to assess the appropriateness of percutaneous transluminal coronary angioplasty 
and coronary artery bypass graft surgery in the Netherlands. The panel, consisting of 
interventional cardiologists and cardiothoracic surgeons, used a modified Delphi process to 
rate 1126 clinical indications over two rounds. This article describes the degree of change in 
both agreement amongst members and in the appropriateness ratings over the two rounds, 
and examines the internal consistency of the ratings of individual panellists. Over the two 
rounds, agreement increased. Although most appropriateness ratings remained unchanged, 
there was significant movement from equivocal ratings to determinate ratings. While 
individual members showed some degree of inconsistency in their scoring, the panel as a 
whole scored very consistently. The observed changes in appropriateness were consistent 
with expectations, showing that the appropriateness method is used logically and consistently 
by panellists. 
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1. Introduction 
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In the absence of large clinical trials, there may be considerable uncertainty 
over the appropriateness of a given medical treatment in relation to specific 
symptoms and the results of tests carried out on a patient. Several studies have 
augmented the scientific evidence with a panel of experts to establish guidelines 
for medical practice [l-3]. In 1991, the Dutch Inventory of Invasive Coronary 
Atherosclerosis Treatments (DUCAT) group assembled a panel of experts to 
establish a rulebase for the use of coronary artery bypass graft surgery (CABG), 
percutaneous transluminal coronary angioplasty (PTCA) and medical therapy 
(MED) for patients with coronary artery disease [4,5]. The rulebase was devel- 
oped using a modified Delphi process; panel members were asked to give their 
opinion as to the appropriateness of the invasive procedures on two occasions, 
once at home with no contact between members, and later after a meeting of all 
members where the results of the first round were discussed. The modified Delphi 
process allows individual members to review and possibly modify their opinions 
through exposure to the opinions of other members and discussion of the differ- 
ences in opinion. 
This process permits a panel member to show substantial changes in opinion. 
There are essentially three reasons why such changes might occur: 
(1) Some members of a given panel will not be familiar with their task and may 
make errors in recording their opinions (for example, scoring a procedure as 
‘appropriate’ where ‘inappropriate’ was intended). Such errors may occur in 
either round, though they would be more likely to occur in the first round when 
panel members are less familiar with the process. However, in a multi-round 
process, factors such as mental fatigue would occur in later chapters of each 
round. 
(2) The re-rating process may cause a panellist to reappraise his own reasons for 
his original decision; such a review is independent of other panel members. 
(3) The feedback of others’ ratings and discussion may cause some individual panel 
members to modify some of their opinions. 
Whatever the reason, some panel members will modify their personal opinion 
as to the appropriateness of an invasive procedure; this expected change is an 
essential characteristic of the modified Delphi process. To gain insight into the 
presence and effect of the factors leading to change, we examined the ratings 
produced by DUCAT panel members. Comparison of the results of the two 
rounds allows assessment of the consistency of the panel and the individual 
members. 
2. Methods 
The DUCAT panel consisted of six interventional cardiologists and six cardio- 
thoracic surgeons, one from each of the 12 of the revascularisation centres then 
operating in the Netherlands. Both academic and non-academic practitioners were 
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included among the 12 panellists. The initial list of indications for PTCA and 
CABG was developed in the United States by a multi-specialty panel of cardiolo- 
gists, cardiothoracic surgeons and internists after a comprehensive literature review 
[6,7]. Following consultation with the members of the DUCAT panel, this list was 
modified to suit the requirements of the DUCAT study and to reflect clinical 
thinking and practice in the Netherlands. Each indication corresponded to a clinical 
scenario consisting of a combination of clinical and laboratory factors considered 
important in the decision to recommend revascularisation and was defined so that 
patients with a given indication could be considered to be reasonably homogenous 
with regards to each treatment. The indications were divided into eight major 
clinical categories corresponding to the patient’s primary underlying medical condi- 
tion (Table 1 lists these groups together with the number of indications within each 
group). An example of an indication is ‘A patient has severe angina while on 
optimal medical therapy, is at low operative risk, has an ejection fraction of more 
than 20% and coronary angiography has demonstrated significant stenosis in the 
proximal left anterior descending artery with a type C lesion’. Each term in the 
indication was defined in a glossary that accompanied the indications. 
For each indication in clinical categories l-6 of Table 1, panel members made 
three two-way comparisons: (1) the appropriateness of PTCA compared to medical 
therapy (PTCA-MED); (2) the appropriateness of CABG compared to medical 
therapy (CABG-MED); and (3) the appropriateness of CABG compared to PTCA 
(CABG-PTCA) on a scale of l-9. For the comparisons PTCA-MED and CABG- 
MED, an indication for which the revascularisation was extremely appropriate was 
rated as 9, with less appropriate indications receiving progressively lower scores 
down to 1 (revascularisation extremely inappropriate); for the comparison CABG- 
PTCA, a score of 9 indicated an extreme preference for CABG, a score of 1 an 
extreme preference for PTCA. An invasive treatment was defined to be appropriate 
if the expected health benefit exceeded the expected negative consequences; simi- 
larly, PTCA was preferred to CABG if the PTCA would benefit the patient more 
than CABG, given the risks involved. For Groups 7 and 8, only one comparison 
per patient was possible (CABG vs. MED and PTCA vs. MED, respectively). Panel 
Table I 
Clinical characteristics of indications 
Group Description (No. of indications) 
Asymptomatic (96) 
Chronic stable angina pectoris (480) 
Unstable angina pectoris (144) 
Acute myocardial infarction (68) 
Post myocardial infarction (200) 
Near sudden death (96) 
CABG combined with valve surgery (2) 
Palliative PTCA (40) 
142 J. McDonnell ef al. / Health Policy 37 (1996) 1.~9. 152 
members were explicitly instructed not to include considerations of cost factors in 
their deliberations. 
The panel completed their ratings twice, once without the opportunity of 
discussion with fellow members of the panel and again, one and a half months 
later, during a 2-day meeting in August 1991 with other panel members. Before 
the second round, each member received a summary of the results of the first 
round giving, for each indication, his own score together with the distribution of 
the scores of all panel members; in this way, individual ratings remained anony- 
mous. The discussion during the meeting was informal and members were encour- 
aged to voice their opinions. Although the discussion centred on those indications 
where there were large differences of opinion, the course of the discussion was 
not limited to choosing a rating number. Instead, the list of indications and the 
definitions of some of the variables were also refined. The panel felt that some 
variables had been too finely detailed, whereas others needed further refinement. 
For example, the ratings for patients with normal left ventricular function, mild 
left ventricular dysfunction and moderate left ventricular dysfunction were so 
similar that these three categories could be taken together. On the other hand, for 
post myocardial infarction patients with continuing or recurrent pain, the panel 
felt that it was necessary to make separate comparisons for patients receiving 
optimal medical therapy and those receiving less than optimal therapy. Therefore, 
comparison of the results in the two rounds is done only on indications common 
to both rounds (for the post myocardial infarction patients, indications involving 
optimal medical therapy in round 2 were used for the comparison, as the physi- 
cians assumed in round 1 that the therapy offered was optimal). The analysis is 
further restricted to Groups l-6 since in Groups 7 and 8, a three-way compari- 
son was not applicable. 
The scores were analysed with respect to the degree of agreement among panel 
members and appropriateness. The definitions used were similar in nature to 
those used by RAND in previous studies of the appropriateness of revascularisa- 
tion [6-81. The panel were said to ‘agree’ if at least nine of the 12 scores lay in 
one of the three-point regions l-3, 4-6, or 7-9, ‘disagree’ if at least four of the 
scores lay in each of the regions l-3 and 7-9; otherwise, the panel were said to 
be ‘indeterminate’ with respect to agreement. An invasive treatment was said to 
be ‘appropriate’ if the median score lay in the region 7-9 without ‘disagreement’, 
‘inappropriate’ if the median score lay in the region l-3 without ‘disagreement’, 
and ‘equivocal’ if the median score lay in the region 4-6 or if there was disagree- 
ment (Table 2). Similarly, for the comparison CABG-PTCA, the panel’s choice 
could be expressed as ‘preference for CABG’, ‘preference for PTCA’ or ‘equivo- 
cal’. 
With these data from two rounds, we examine four questions which address 
the issue of panel consistency: 
(1) To what degree did ‘agreement’ change between the two rounds? (agreement 
would naturally be expected to increase from round 1 to round 2). 
(2) To what degree did ‘appropriateness’ change? 
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Table 2 
Panel appropriateness rating based on degree of agreement among panelists and median panel rating 
Median panel score of appropriateness Degree of agreement 
Agreement Indeterminate Disagreement 
1-3 Inappropriate Inappropriate Equivocal 
4-6 Equivocal Equivocal Equivocal 
7-9 Appropriate Appropriate Equivocal 
See Section 2 for definitions. 
(3) Do the individual ratings show internal (logical) consistency (as measured by 
the transitivity of the three ratings for each indication)? 
(4) Can a learning process be discerned for some panel members? 
3. Results 
Although an increase in agreement was not explicitly sought, ‘agreement’ as 
defined should be greater in round 2 than in round 1 while ‘disagreement’ and 
‘indeterminate’ can both be expected to decrease over rounds. This was found to 
be true for all three comparisons (Table 3). Roughly one-sixth of all ratings 
shifted from less-than-agreement to agreement, while roughly one-half of dis- 
agreements were resolved. 
The overall pattern was evident in all six clinical categories. 
Changes in the distribution of ‘appropriateness’ were also found. The results, 
for each of the two-way comparisons, are given in Tables 4-6. 
Table 3 
Agreement ratings per comparison per round 
Comparison Round % Agreement % Disagreement % Indeterminate P-value* 
PTCA-MED 1 43.3 7.1 49.6 <O.OOi 
2 62.1 3.5 34.4 
CABG-MED 1 31.1 9.2 53.0 <O.OOl 
2 53.1 5.4 41.0 
CABG-PTCA 1 34.1 1.5 63.8 <O.OOl 
2 60.1 0.6 39.3 
*Test of marginal homogeneity. 
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Table 4 
Appropriateness of PTCA compared to medical therapy by Rating round (number of indications as a 
percentage given in brackets) 
Round 1 Round 2 
Appropriate Equivocal Inappropriate Total 
Appropriate 175 (16.1) 1 (0.1) 0 (0.0) 176 (16.2) 
Equivocal 47 (4.3) 215 (19.8) 44 (4.1) 306 (28.2) 
Inappropriate 0 (0.0) 27 (2.5) 575 (53.0) 602 (55.5) 
Total 222 (20.5) 243 (22.4) 619 (57.1) 1084 
Table 5 
Appropriateness of CABG compared to medical therapy by Rating round 
Round 1 Round 2 
Appropriate 
Equivocal 
Inappropriate 
Total 
Appropriate 
336 (31.0) 
54 (5.3) 
0 (0.0) 
390 (36.0) 
Equivocal 
3 (0.3) 
278 (25.6) 
19 (1.8) 
300 (27.7) 
Inappropriate 
0 (0.0) 
40 (3.7) 
354 (32.7) 
394 (36.3) 
Total 
339 (31.3)) 
372 (34.3) 
373 (34.4) 
1084 
Table 6 
The appropriateness of CABG compared to PTCA by Rating round 
Round 1 Round 2 
Appropriate Equivocal Inappropriate Total 
Appropriate 261 (24.1) 9 (0.8) 0 (0.0) 270 (24.9) 
Equivocal 35 (3.2) 405 (37.4) 41 (3.8) 481 (44.4) 
Inappropriate 0 (0.0) 6 (0.6) 327 (30.2) 333 (30.7) 
Total 296 (27.3) 420 (38.7) 368 (33.9) 1084 
The transition patterns for all three comparisons are generally similar. The 
number of comparisons which remained unchanged was high (89% PTCA-MED, 
89% CABG-MED, 92% CABG-PTCA). Correspondingly, the median scores under- 
lying the rating categorisation were stable; only about 2.5% of the ratings had a 
shift of median greater than 2 points on the 9-point scale. There was no indication 
that shifted two steps (inappropriate to appropriate or vice-versa) between rounds; 
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The transition patterns for all three comparisons are generally similar. The 
number of comparisons which remained unchanged was high (89% PTCA-MED, 
89% CABG-MED, 92% CABG-PTCA). Correspondingly, the median scores under- 
lying the rating categorisation were stable; only about 2.5% of the ratings had a 
shift of median greater than 2 points on the 9-point scale. There was no indication 
that shifted two steps (inappropriate to appropriate or vice-versa) between rounds; 
indeed, movement away from an appropriate or inappropriate rating was rare. 
There was a significant amount of movement (P < 0.001 for all three ratings) from 
an equivocal rating to an appropriate or inappropriate one, with that movement 
not being dominated by either an upward (towards appropriate) or downward 
(towards inappropriate) shift. 
The vast majority of the shifts in appropriateness category were caused by the 
movement of the group median as opposed to the disappearance of disagreement; 
for example, of the 91 PTCA-MED shifts from equivocal, only seven were for 
resolution of disagreement without a change of median. Analyses not shown here 
indicate that all six clinical characteristic groups behaved similarly with respect to 
changes in appropriateness category. 
3.1. Variations in individual scores 
Although the panel group score is quite stable, panel members changed their 
individual scores, in some cases quite dramatically. For each member, we calculated 
the frequency and percentage of indications changed by three or more points from 
round 1 to round 2. We also calculated these statistics for ‘severe’ change, defined 
as a shift from appropriate (7-9) to inappropriate (l-3) or vice-versa. We reasoned 
that severe changes would most likely come from correction of a rating ‘error’ or 
from redefinition of a term, whereas ‘moderate’ changes of 3 or more points that 
were not severe would most likely reflect a true opinion change. 
Table 7 shows how individual panellists changed. Overall, individual members 
changed between 114 (3.5%) and 583 (17.9%) of the more than 3200 ratings they 
made. Panellists could be grouped as making relatively frequent (309 or more) 
changes (members 1, 3, 4, 9, 10 and 12) or relatively rare (231 or fewer) changes 
(members 2, 5, 6, 7, 8 and 11). Among panellists, between 10 (0.3%) and 236 (7.2%) 
severe changes were made. Almost the same grouping of panellists could be made 
for changes as for severe changes, with five members having 89 or more and seven 
members having 69 or fewer. Panellist 12 was an outlier, although he was classified 
as a frequent changer, he made the fewest severe changes. For this panellist, only 
3% of all changes were severe, while for the rest of the panellists, that statistic 
ranged from 18.6% to 40.5%. 
We conclude that understanding of the process and definitions was a significant 
factor in panellist change propensity, but that this factor was not (except for panel 
member 12) related to general propensity to change ratings. 
For each member, we calculated a measure of how that individual’s scores differ 
from those of the group. For the ith member, this mean absolute deviation score is 
defined by IMAD; = ZilX, - Mil/ n w h ere Xi = the score given by panel member 
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i for indication j, Mj = the median panel score for indication j and n = the 
number of indications. This measure contrasts with the usual MAD which is a 
measure of the variation present in a group of observations. 
Each member’s IMAD was smaller in round 2 than in round 1, as would be 
expected in the presence of increasing agreement (Table 8). 
Panel members 1, 3, 4, 9 and 12 had the greatest change in IMAD, indicating a 
tendency to score more towards the median score in round 2 than in round 1; their 
scores were generally more in line with those of other members of the panel in 
round 2 than they had been in round 1. Panellist 5 had the largest IMAD but the 
difference between the MADs was one of the smallest; his scores differed, on 
average, by approximately 2 points from the group median in both rounds. 
Members 1 and 3 differed much more from their colleagues in round 1 than in 
round 2, confirming that these members did indeed undergo a learning process. 
Although panellist 9 had a large number of substantial changes in his scores, in 
neither round did he differ markedly from his colleagues. 
4. Transitivity 
To check on the internal consistency of the ratings, we examined the transitivity 
of the panel appropriateness score for the two rounds. Here, we say X > Y (is 
preferred to) if X is rated appropriate compared to Y (or Y is inappropriate 
compared to x). We consider X = Y if the X vs. Y rating is equivocal. We then 
say that an indication is transitive if the following condition is fulfilled:if X r Y 
and Y 2 2 then X 2 Z; if one or more of the relationships X-Y, Y-Z is strict 
(preference = ‘ > ‘), then X > Z. If an indication is not transitive, it is said to be 
intransitive. 
Table 8 
Individual mean .absolute deviations, by round 
Member IMAD round 1 IMAD round 2 Difference between rounds 
I 1.5678 0.9133 0.6545 
2 1.1345 1.0132 0.1213 
3 I .9500 1.2109 0.7391 
4 1.3796 0.8915 0.4882 
5 2.0816 1.9714 0.1102 
6 0.9734 0.9194 0.0540 
7 1.2711 1.2168 0.0543 
8 1 I265 1.2764 0.3501 
9 1.3073 0.8416 0.4657 
10 1.5580 1.2057 0.3522 
11 1.3562 1.0824 0.2738 
12 1.3996 0.8998 0.4998 
Mean over members I.467 I 1.202 0.3469 
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We make the distinction between strong and weak transitivity. An indication is 
strongly intransitive if X > Y and Y > 2 but Z 2 X. An indication is weakly 
intransitive if X = Y and Y = Z but X > ,Z (or Z > X). Note that a weakly 
intransitive indication may not represent a logical inconsistency. For example, the 
panel may have a very slight preference for PTCA over MED (but not sufficiently 
strong for PTCA to be rated as ‘appropriate’) and a slight preference for CABG 
over PTCA (again, not sufficiently strong for CABG to be judged as ‘preferred’ to 
PTCA); the combinations of these individually weak preferences may cause the 
panel to decide that CABG is indeed ‘preferred to MED’. Such an indication would 
be rated as weakly intransitive under the above definition. We have not made the 
further distinction between ‘possibly’ transitive and other weakly intransitive indi- 
cations. 
Strongly intransitive indications do represent a logical inconsistency. The pres- 
ence of a relatively large number of strongly intransitive indications would possibly 
imply that the three two-way comparisons were not being carried out on the same 
scale, i.e. one or more extra factors, such as the cost of the procedure, were entering 
into the panel’s considerations. Clearly, the presence of many strongly intransitive 
indications would indicate that the panel was not able to clearly compare the three 
treatments. 
Since each of the three comparisons has three possible outcomes (appropriate/ 
equivocal/inappropriate or PTCA/equivocal/CABG), there are 27 possible combi- 
nations, of which 13 are transitive, eight are strongly intransitive, and six are 
weakly intransitive. These combinations are listed in Table 9, together with the type 
of intransitivity and the number of indications with that combination found in the 
panel data. 
Taking panel median ratings, there were 10 (0.9%) strongly intransitive combina- 
tions in round I and 14 (1.3%) in round 2. There were 232 (21.4%) weakly 
intransitive combinations in round 1 and 186 (17.2O/;) in round 2; this reduction was 
significant (P < 0.001, McNemar’s test). Overall, more than 80% of the indications 
are rated transitively by the panel. 
For all indications in round 2 in which strong intransitivity was found, the 
indications involved a C lesion, while in round 1, seven of the indications involved 
a C lesion. Similarly, almost all the intransitive indications in round 2 involved 
two-vessel disease (with or without the involvement of the proximal left anterior 
descending) or one vessel disease with proximal left anterior descending involve- 
ment, and low operative risk; in round 1, several indications for left main disease 
or three-vessel disease, or for high operative risk were intransitively scored. The 
treatment of C lesions is an area where change is rapid and this is reflected in the 
fact that the panel opinion is not clearly expressed; similarly, the treatment 
preferred for patients suffering from moderate disease is an area where less clarity 
is to be found. 
The fact that few of the indications were strongly intransitive indicates that the 
panel as a whole generally understood the method. Individual members however 
showed considerable variation in the number of intransitive indications (Table 10). 
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Table 9 
Group patterns of transitivity 
PTCA-MED CABG-MED CABG-PTCA Type of intransitivity Round 1 Round 2 
P C C 0 3 
P C E 21 34 
P C P 28 49 
P E C Strong 0 0 
P E E Weak 12 2 
P E P 94 104 
P M C Strong 0 0 
P M E Strong 0 0 
P M P 21 30 
E C C 28 35 
E C E Weak 56 31 
E C P Strong 0 0 
E E C Weak 2 3 
E E E 85 41 
E E P Weak 39 23 
E M C Strong 0 0 
E M E Weak 18 17 
E M P 78 87 
M C C 198 218 
M C E Strong 8 14 
M C P Strong 0 0 
M E C 41 34 
M E E Weak 97 93 
M E P Strong 2 0 
M M C 1 3 
M M E 185 183 
M M P 71 15 
Total strongly intransitive ratings 10 (0.9%) 14 (1.3%) 
Total weakly intransitive ratings 224 (21.4%) 186 (17.2%) 
Total intransitive ratings 234 (22.3%) 200 (18.5%) 
The letter C, M or P indicates a preference for that procedure (CABG, MED, PTCA, respectively), while 
E indicates equivocation in the comparison. 
Each panellist made between 1000 and 1100 three-part ratings per round. On 
round 1, panellists 2 and 6 had very few strongly intransitive ratings, while 
panellists 2, 11 and especially 3 were high (55 10%). Most panellists had between 20 
and 32 strongly intransitive ratings ( > 3%). In round 2, six panellists increased their 
frequency of strongly intransitive and six decreased; in this round, six panellists had 
more than 3% strongly intransitive. With respect to weak intransitivity, the panel- 
lists split on round 1 into a low group of seven members (range 1 1 - 114 or 1 - 10%) 
and a high group of five members (range 183-270 or 16-25%). No member 
switched groups between round 1 and 2, although three members formed a middle 
group around 13% weakly intransitive. Propensity to form strongly intransitive 
combinations did not appear to be related to the propensity to form weakly 
intransitive patterns. 
150 J. McDonnell et 01. /I Hralth Poliq 37 (1996) 139- 153 
5. Conclusion and discussion 
In general, the results of the two rounds showed reasonable consistency, but also 
considerable and important changes between rounds. 
First, there was a substantial increase in the degree of agreement amongst panel 
members together with a corresponding decrease in disagreement. Such an increase 
was to be expected as members could listen to the opinions of others and their 
understanding of the panel process grew. Similar changes have been noted by Park 
et al. [2] and Leape et al. [9]. Park et al. [2] rated six medical and surgical 
procedures, using four different definitions of agreement. Substantial increases in 
agreement were observed for four procedures, with little change for the other two. 
Second, there was a decrease in the number of indications rated equivocal by the 
panel with a movement towards both appropriate and inappropriate. This change 
was mainly due to changes in the median opinion of the panel and was only slightly 
due to the decrease in disagreement. Again, this parallels some but not all earlier 
findings. The fact that approximately 90% of all indications were rated identically 
over the two rounds shows that the appropriateness ratings are very stable. 
Third, most individual members scored relatively few indications strongly intran- 
sitively, indicating that they generally had a good understanding of the concept of 
the comparisons. The panel as a group scored very few strongly intransitive 
combinations and these were largely concentrated in indications involving a C 
lesion, reflecting the perceived difficulties involved in treating a type C lesion. 
Finally, several members appear to have undergone a process of learning during 
the first round. They changed many of their ratings quite dramatically, possibly due 
to misunderstandings of procedures or misunderstandings in the first round. 
Although changes were observed between the two rounds, the overall stability of 
ratings indicates that a third round would not lead to further substantial changes. 
Changes due to misunderstandings would disappear and there is no indication that 
intransitivities would decrease. 
In summary, the observed changes in appropriateness ratings were consistent 
with expectations both in magnitude and direction. The ratings obtained show 
stability and are consistent with perceived medical thought. The observed panellist 
changes show the advisability of multiple rounds of ratings. Based on an internal 
analysis of the DUCAT study, the modified Delphi process offers a consistent 
method of determining the appropriateness of alternative treatments. 
Table 10 
Number of intransitively scored indications per panel member per round 
Member Round 1 2 3 4 5 6 7 8 9 10 I 1 12 
Strong 1 32 54 100 31 23 7 21 31 30 27 69 2 
2 39 77 42 22 18 8 19 19 34 42 33 4 
Weak 1 183 183 50 192 11 82 201 201 270 89 94 114 
2 147 147 71 141 41 89 248 248 192 127 Ill 142 
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Appendix A: Marginal symmetry 
The P-values reported in Section 3 are those of a test of marginal symmetry in 
a square contingency table. As this test may not be familiar to many practi- 
tioners, we include a short description of it. Further details may be found in 
Agresti [lo]. 
The results of the comparison of the two rounds were displayed in a 3 x 3 
contingency table e.g. the appropriateness rating for PTCA (vs. medical therapy) 
was given in Table 4. More generally, such a table can be represented as 
4, n12 n13 nl+ 
‘121 h2 n23 n2+ 
n31 n32 n33 ‘23+ 
where ni+ = nil + n, + ni3 for i = 1-3, and n +.i is similarly defined (j = 
I-3). 
The null hypothesis is that the distribution of the appropriateness ratings is the 
same for rounds 1 and 2 i.e. ni+ = n + I for i = l-3 against the alternative 
hypothesis that ni + # n + i for some i. 
Note that since n,, + n2+ + n3+ = n,, + nt2 + n,, = n, +, one of 
the equations involved is redundant. 
Clearly, if the null hypothesis is true, the vector d, where d has elements d, = 
h, -  n+i>/n+ + has expected value 0. The vector d has length 2 because of the 
redundancy noted above. Under the null hypothesis, the estimated variance ma- 
trix of d has elements wii = (n,, + n, i - 2nij)/nji (i = 1,2) and wii = - (n,, 
+ nJn+ + (i = 1,2;j = 1,2; i # j). 
The test statistic is then Q = n, + d’W - ‘d which under the null hypothesis 
has a chi-squared distribution with two degrees of freedom. 
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